Brief: Captor Therapeutics Appoints Michal Walczak As CEO
30/05/2025 17:37
May 30 (Reuters) - Captor Therapeutics SA CTXP.WA: THOMAS SHEPHERD RESIGNS AS PRESIDENT OF CAPTOR THERAPEUTICS MICHAl WALCZAK APPOINTED PRESIDENT OF CAPTOR THERAPEUTICS ANNA PAWLUK APPOINTED CHIEF OPERATING OFFICER OF CAPTOR THERAPEUTICS TOMAS DRMOTA APPOINTED CHIEF TECHNOLOGY OFFICER OF CAPTOR THERAPEUTICS Source text: nEM37K3Dza Further company coverage: CTXP.WA (Reporting by Gdańsk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Captor Therapeutics SA
See all newsBrief: Captor Therapeutics To Issue 8934 Series Z Shares For Incentive Programme Purpose
Brief: Captor Therapeutics Q1 Net Loss At 11.4 Million Zlotys
Brief: Captor Therapeutics FY Net Loss At 42.0 Million Zlotys
Brief: Captor Therapeutics To Sell 800,000 Y Series Shares At 82 Zlotys/Shr
Brief: Captor Therapeutics Starts ABB Process For Up To 800,000 New Series Y Shares